scholarly journals Business models and investment trends in the biotechnology industry in Europe

2002 ◽  
Vol 8 (3) ◽  
Author(s):  
Jane Fisken ◽  
Jan Rutherford
Keyword(s):  
Business Models ◽  
Biotechnology Industry ◽  
Biotechnology Company ◽  
Public And Private ◽  
Public Markets ◽  
European Public ◽  
Private Markets

Presents a study that assessed the evolution of biotechnology company business models in relation to investment trends in the European public and private markets and the biotechnology industry, as of December 2001. Review of various aspects of several business models; Discussion on investment trends in public markets; Outlook for biotechnology business models.

Urban Alternatives: Public and Private Markets in the Provision of Local Services

1992 ◽  
Vol 11 (2) ◽  
pp. 338
Author(s):  
Steven Rathgeb Smith ◽  
Robert M. Stein ◽  
Terry L. Anderson ◽  
Donald R. Leal
Keyword(s):  
Public And Private ◽  
Local Services ◽  
Private Markets

scholarly journals Analysis of the Contribution of Small Residential Care Centers for the Elderly to reduce the Socio Environmental Impact and Foster Entrepreneurship in Brazilian Megacities (São Paulo)

2016 ◽  
Vol 7 (3) ◽  
pp. 103 ◽  
Author(s):  
Heloisa Candia Hollnagel ◽  
Luiz Jurandir Simões De Araújo ◽  
Ricardo Luiz Pereira Bueno
Keyword(s):  
Business Models ◽  
Elderly Care ◽  
Care Center ◽  
Life Quality ◽  
The Elderly ◽  
Work Place ◽  
Decent Work ◽  
Urban Centers ◽  
Public And Private ◽  
Peripheral Areas

On 2016 the 17 United Nations Sustainable Development Goals (SDGs) of the 2030 Agenda officially came into force proposing that Governments can work to promote inclusive and sustainable economic growth, employment and decent work for all. This study aims to analyze the contribution of Residential Elderly Care Center – RECC to promote SD along with social support in urban centers of megacities. Considering that the current scenario presents: longer life expectancy and increasing numbers of older people; the growing presence of women in the market and the hierarchy of companies making more and more difficult for them to stay at home as well as the failure of public care structure to respond adequately to citizens’ demands new business models are welcome. While the families are getting smaller which removes potential caregivers within them, conversely mobility issues among peripheral areas and public institutions are increasing. Large arrangements for caring can be useful in some contexts, but generally, require commuting from home to the support structure and new public and private investments. The potential reduction of human daily dislocations could improve the environment and life quality in megacities in many aspects: decreasing vehicles CO2 emissions, pollution and the volume of traffic; giving practicality to everyday life of families with dependent members of care and generating new opportunities of small business. In addition, this new residential structures employment might reduce the need to shift the caregivers themselves to their work place, strengthen community bounds and not require immobilization of new properties of the exclusive use for Care centers in highly urbanized areas. The methodology used in this paper is based in the exploratory-descriptive and bibliographical-documentary method. Results of the study are corroborated by a series of complementary research of the authors. Conceptual step-by-step flowchart to assist an entrepreneur to open a RECC is described.

scholarly journals Towards Net Zero export credit: current approaches and next steps

2021 ◽  
Author(s):  
Thomas Hale ◽  
Andreas Klasen ◽  
Norman Ebner ◽  
Bianca Krämer ◽  
Anastasia Kantzelis
Keyword(s):  
Business Models ◽  
Global Climate ◽  
Export Credit ◽  
Public And Private ◽  
Climate Targets ◽  
Net Zero ◽  
The Many ◽  
The One ◽  
Investment Portfolios ◽  
Export Credit Agencies

As the world economy rapidly decarbonises to meet global climate goals, the export credit sector must keep pace. Countries representing over two-thirds of global GDP have now set net zero targets, as have hundreds of private financial institutions. Public and private initiatives are now working to develop new standards and methodologies for shifting investment portfolios to decarbonisation pathways based on science. However, export credit agencies (ECAs) are only at the beginning stages of this seismic transformation. On the one hand, the net zero transition creates risks to existing business models and clients for the many ECAs, while on the other, it creates a significant opportunity for ECAs to refocus their support to help countries and trade partners meet their climate targets. ECAs can best take advantage of this transition, and minimise its risks, by setting net zero targets and adopting credible plans to decarbonise their portfolios. Collaboration across the sector can be a powerful tool for advancing this goal.

scholarly journals Time for a new business model?

1969 ◽  
Vol 16 (1) ◽  
Author(s):  
Yali Friedman
Keyword(s):  
Business Model ◽  
Hybrid Model ◽  
Business Models ◽  
The United States ◽  
Biotechnology Industry ◽  
New Firms ◽  
Technology Platform ◽  
Economic Climate ◽  
New Business ◽  
Biotechnology Companies

In the relatively short history of the biotechnology industry, new business models have emerged every few years. Some have been little more than short-lived marketing or investment-attraction devices, whereas others have had endured as viable options. Given the dramatic changes in the economic climate and potentially the regulations affecting biotechnology, is it time for a new business model?A SHORT HISTORYFirst there was the FILCO, or fully integrated life science company, business model. This model, employed by some of the first biotechnology companies, positioned firms to capture the revolutionary advances of biotechnology and to build large vertically-integrated companies. Companies like Amgen and Genentech were able to fulfill this endpoint, but many other companies were not so fortunate. Another early model was to improve existing products, rather than to build an entire franchise around discovering and commercializing new ones. This model is exemplified by Alza, which was founded to improve medical treatment through controlled drug delivery and focused on improving existing drugs rather than developing new ones. This same model is still employed today, and shares some similarity with the technology platform business model, where companies focus on developing technologies that can be sold to other R&D firms, rather than independently developing consumer applications.Newer business models did not replace the older ones, but rather enabled new firms to focus on the unique environment in which they were founded. Examples include the hybrid model that combined product development with a technology platform, which could be sold or licensed to others, and the no research, development-only model that as a derivative of the specialty pharmaceutical model, saw newly founded companies buying drug leads off of other companies to complete late-stage clinical trials. These models enabled new firms to meet the respective needs of risk-averse and cash-rich investors.WHERE ARE WE NOW?I've previously written that the global economic crisis has been (and still is) transformative for the biotechnology industry. The aforementioned biotechnology business models rose to prominence in conditions that favored them. For example, the hybrid model emerged in a funding drought and was favored as it enabled companies to build internal revenue streams while still maintaining the possibility to realize the upside of product sales.What are the factors influencing biotechnology companies today? In the United States, beyond the general economic climate there are still unresolved questions about the availability of early stage financing, the ability to recruit foreign workers, and – post-commercialization – data exclusivity, generic biologics and the potential for price controls. Internationally, some nations are still undergoing dramatic economic reorganizations, while others are making significant investments in building biotechnology R&D capacity.So, the question remains: Is the biotechnology industry ready for a new business model, and is there a business model that can accommodate the myriad domestic challenges faced by many countries while addressing the increasing globalization of activities?

Privacy Concerns for Ubiquitous Data Aggregation and Storage

2014 ◽  
Author(s):  
Jarrod M. Rifkind ◽  
Seymour E. Goodman
Keyword(s):  
World Bank ◽  
High Performance ◽  
Business Models ◽  
The United States ◽  
Third Party ◽  
The Internet ◽  
Public And Private ◽  
Personal Lives ◽  
The Public ◽  
The World

Information technology has drastically changed the ways in which individuals are accounted for and monitored in societies. Over the past two decades, the United States and other countries worldwide have seen a tremendous increase in the number of individuals with access to the Internet. Data collected by the World Bank shows that 17.5 of every 100 people in the world had access to the Internet in 2006, and this number increased to 23.2 in 2008, 29.5 in 2010, and 32.8 in 2011 (World Bank 2012). According to the latest Cisco traffic report, Internet traffic exceeded 30 exabytes (1018 bytes) per month in 2011 and is expected to reach a zettabyte (1021 bytes) per month by 2015 (Cisco Systems 2011). Activities on the Web are no longer limited to seemingly noncontroversial practices like e-mail. The sheer growth of the Internet as a medium for communication and information sharing as well as the development of large, high-performance data centers have made it easier and less expensive for companies and governments to aggregate large amounts of data generated by individuals. Today, many people’s personal lives can be pieced together relatively easily according to their search histories and the information that they provide on social networking websites such as Facebook and Twitter. Therefore, technological breakthroughs associated with computing raise important questions regarding information security and the role of privacy in society. As individuals begin using the Internet for e-commerce, e-government, and a variety of other services, data about their activities has been collected and stored by entities in both the public and private sectors. For the private sector, consumer activities on the Internet provide lucrative information about user spending habits that can then be used to generate targeted advertisements. Companies have developed business models that rely on the sale of such information to third-party entities, whether they are other companies or the federal government. As for the public sector, data collection occurs through any exchange a government may have with its citizens.

scholarly journals Changes in the provision of health care in South Africa

2004 ◽  
Vol 35 (3) ◽  
pp. 1-11 ◽  
Author(s):  
J. Luiz ◽  
M. Wessels
Keyword(s):  
South Africa ◽  
Health Care ◽  
Business Models ◽  
Future Directions ◽  
Public And Private ◽  
Current Structure ◽  
The Public ◽  
Healthcare Market

Health care in South Africa is undergoing substantial changes with rising pressure on both the public and private sectors. Medical inflation has been soaring rendering healthcare increasingly unaffordable and medical schemes have had to adapt their traditional business models. This paper looks at the current structure of the healthcare market; it examines the new legislation introduced by government, and assesses future directions of healthcare in South Africa.

The characteristics of bioentrepreneurs in the Australian biotechnology industry: A pilot study

2007 ◽  
Vol 13 (4) ◽  
pp. 383-406
Author(s):  
Julian W Yim ◽  
Rae Weston
Keyword(s):  
Pilot Study ◽  
Personality Traits ◽  
Big Five ◽  
Strategic Alliance ◽  
Biotechnology Industry ◽  
Public And Private ◽  
Managerial Skills ◽  
Big Five Model ◽  
Five Factors ◽  
Linkage Relationships

AbstractIn order to understand the characteristics of bioentrepreneurs, this paper seeks to identify the entrepreneurial types present in the Australian biotechnology industry by using the four-way psychological typology (Miner 2000) and identifying linkages between the four-way psychological typology and the Big Five model of personality traits. We believe this is a new approach to using psychological typology in the study of entrepreneurship by mapping with the Big Five model of personality traits. Miner's four typological types are ‘personal achievers’ (PA), ‘super sales people’ (SS), ‘expert idea generators’ (EI) and ‘real managers’ (RM). The Big Five factors are extraversion (Ex), stability/emotion stability (Es), agreeableness (Ag), conscientiousness (Co), and openness to experience (Op). By combining the entrepreneurial types and the five-factor personality traits, we can map the linkage relationships as PA-ExEsCoOp; SS-ExAgCoOp; EI-ExEsOp and RM-ExEsCoOp.In this pilot study, we find there are more ‘personal achiever’ and ‘expert idea generator’ bioentrepreneurs in the biotech industry with the linkage relationships of PA-ExEsCoOp and EI-Ex EsOp, which lead us to conclude there are strong demands for bioentrepreneurs with managerial skills, sales and marketing skills, skills in forming strategic alliance with partners and skills in securing the public and private capitals through finance channels such as public listing and venture capital. This implies that if PA entrepreneurs acquired more agreeableness personality traits and EI entrepreneurs also acquired more agreeableness and conscientiousness personality traits they would improve the ability of their businesses to attract more financial investments and form sustainable strategic alliance with partners in the Australian biotechnology industry.

scholarly journals The impact of supervisor-nurse relationships, patient role clarity, and autonomy upon job satisfaction: Public and private sector nurses

2012 ◽  
Vol 18 (5) ◽  
pp. 659-672 ◽  
Author(s):  
Kate Shacklock ◽  
Yvonne Brunetto ◽  
Rod Farr-Wharton
Keyword(s):  
Job Satisfaction ◽  
Public Sector ◽  
Private Sector ◽  
Business Models ◽  
Healthcare Sector ◽  
Role Clarity ◽  
Public And Private ◽  
Patient Role ◽  
Public And Private Sector ◽  
The Impact

AbstractIn the Australian healthcare sector, many changes in the public sector have affected nurse management and thereby, nurses. Yet it is unclear whether such efficiency measures, based on private sector business models, have impacted private sector nurses in similar ways. This paper examines four important issues for nurses: supervisor–subordinate relationships; perceptions of autonomy; role clarity in relation to patients; and job satisfaction. The paper uses an embedded mixed methods research design to examine the four issues and then compares similarities and differences between public and private sector nurses. The findings suggest supervisor–subordinate relationships, patient role clarity and autonomy significantly predict job satisfaction. The private sector nurses reported more satisfaction than public sector nurses with their supervisor–subordinate relationships, plus higher perceptions of patient role clarity and autonomy, and hence, higher levels of job satisfaction. The findings raise questions about whether present management practices (especially public sector) optimise service delivery productivity.

Sign in / Sign up

Export Citation Format

Share Document